C Haas

507 total citations
16 papers, 406 citations indexed

About

C Haas is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, C Haas has authored 16 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in C Haas's work include Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (6 papers) and Virology and Viral Diseases (4 papers). C Haas is often cited by papers focused on Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (6 papers) and Virology and Viral Diseases (4 papers). C Haas collaborates with scholars based in Germany, Thailand and France. C Haas's co-authors include Volker Schirrmacher, Roswitha Gerhards, R Bonifer, T. Ahlert, Markus R. Meyer, Frank T. Peters, Hans H. Maurer, Christoph Sauer, Giselher Fritschi and Annette Arnold and has published in prestigious journals such as Cancer Research, International Journal of Cancer and Vaccine.

In The Last Decade

C Haas

16 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Haas Germany	10	178	124	121	119	92	16	406
Julia L. Rintoul Canada	7	361 2.0×	68 0.5×	180 1.5×	170 1.4×	52 0.6×	7	684
L. Zhong United States	13	28 0.2×	156 1.3×	55 0.5×	106 0.9×	32 0.3×	27	433
Joanne Kivela Tillotson United States	6	49 0.3×	198 1.6×	39 0.3×	93 0.8×	19 0.2×	12	366
Russell E. McDaniel United States	11	187 1.1×	51 0.4×	12 0.1×	170 1.4×	19 0.2×	15	421
Iris B. Parr United Kingdom	9	160 0.9×	28 0.2×	142 1.2×	152 1.3×	17 0.2×	17	441
Jie Qing China	16	17 0.1×	113 0.9×	80 0.7×	256 2.2×	12 0.1×	28	604
I Cerutti France	13	54 0.3×	74 0.6×	112 0.9×	201 1.7×	14 0.2×	36	476
Bryan O’Hara United States	11	52 0.3×	238 1.9×	58 0.5×	130 1.1×	16 0.2×	13	385
Alexandre Budu Brazil	14	19 0.1×	144 1.2×	82 0.7×	141 1.2×	12 0.1×	34	516

Countries citing papers authored by C Haas

Since Specialization

Citations

This map shows the geographic impact of C Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Haas more than expected).

Fields of papers citing papers by C Haas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Haas. The network helps show where C Haas may publish in the future.

Co-authorship network of co-authors of C Haas

This figure shows the co-authorship network connecting the top 25 collaborators of C Haas. A scholar is included among the top collaborators of C Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Haas. C Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Haas, C, et al.. (2020). COVID-19 and true solidarity on the internet. Zenodo (CERN European Organization for Nuclear Research). 3 indexed citations

Sauer, Christoph, Frank T. Peters, C Haas, et al.. (2009). New designer drug α‐pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry. 44(6). 952–964. 77 indexed citations

Nair, Jagadeesan, Petcharin Srivatanakul, C Haas, et al.. (2009). High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 683(1-2). 23–28. 48 indexed citations

Haas, C, et al.. (2005). A tumor vaccine containing anti‐CD3 and anti‐CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. International Journal of Cancer. 118(3). 658–667. 24 indexed citations

Nair, Jagadeesan, Alexander Frank, C Haas, Helmut K. Seitz, & Helmut Bartsch. (2004). 1,N6-ethenodeoxyadenosine,a lipid peroxidation induced DNA adduct in alcoholic liver disease. Cancer Research. 64. 452–452. 1 indexed citations

Haas, C, et al.. (2004). T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine. Vaccine. 23(19). 2439–2453. 22 indexed citations

Schirrmacher, Volker, et al.. (1999). Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Gene Therapy. 6(1). 63–73. 121 indexed citations

Haas, C, Christel Herold‐Mende, Roswitha Gerhards, & Volker Schirrmacher. (1999). An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules. Cancer Gene Therapy. 6(3). 254–262. 6 indexed citations

Schirrmacher, Volker & C Haas. (1998). Modification of Cancer Vaccines by Virus Infection and Attachment of Bispecific Antibodies. Advances in experimental medicine and biology. 451. 251–257. 4 indexed citations

10.

Haas, C, et al.. (1998). Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus.. International Journal of Oncology. 13(6). 1105–15. 28 indexed citations

11.

Haas, C, Gudrun Strauß, G Moldenhauer, Ronald M. Iorio, & Volker Schirrmacher. (1998). Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine.. PubMed. 4(3). 721–30. 18 indexed citations

12.

Schirrmacher, Volker, et al.. (1997). Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection.. PubMed. 3(7). 1135–48. 29 indexed citations

13.

Haas, C & Volker Schirrmacher. (1996). Immunogenicity increase of autologous tumor cell vaccines by virus infection and attachment of bispecific antibodies. Cancer Immunology Immunotherapy. 43(3). 190–194. 13 indexed citations

14.

Jurianz, K., C Haas, Marcus Hubbe, et al.. (1995). ADHESIVE FUNCTION OF NEWCASTLE-DISEASE VIRUS HEMAGGLUTININ IN TUMOR-HOST INTERACTION. International Journal of Oncology. 7(3). 539–545. 10 indexed citations

15.

Lowenstein, W, et al.. (1994). [Do substitution treatments reduce the incidence of human immunodeficiency virus infections in intravenous heroin addicts? Review of pertinent literature].. PubMed. 145 Suppl 3. 75–8. 1 indexed citations

16.

Haas, C, et al.. (1989). [Chronic lymphocyte sialadenitis related to Gougerot-Sjögren syndrome disclosing HIV seropositivity. A case].. PubMed. 140(3). 214–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact